In this Q&A, Del Smith, PhD, CEO and co-founder of Acclinate, discusses how structural and relational barriers continue to limit participation from underrepresented communities in clinical trials—and ...

In this video interview, Abraham Gutman, founder and CEO of AG Mednet, describes how AI can take on rote reasoning tasks like PHI redaction and document QA, and why offloading that work is what gives ...

In a new video interview, Abraham Gutman, founder and CEO of AG Mednet, explained why data capture advances have not addressed the underlying execution problem in clinical trials and what a practical ...

Across 42 coordinators (mean 6.2 years’ experience), only 45% of problems were identified on average, indicating substantial ...

In a recent video interview with Applied Clinical Trials, Abraham Gutman, founder and CEO of AG Mednet, discussed the concept ...

Vendor capability gaps and failed implementations erode sponsor trust, while complex neurocognitive instruments can be ...

In this video interview, Sam Hinsley, statistics manager at Phastar, explains why early phase decisions are the foundation of the entire development pathway and what is at stake statistically when ...

Shareholder votes in 2025 uniformly rejected anti-DEI proposals, while many sponsors rebrand DEI under culture, belonging, and performance rather than dismantling commitments. Heightened DOJ/EEOC ...

In this video interview, Sam Hinsley, statistics manager at Phastar, introduces the Early Phase ESIG, a new special interest ...

In this Q&A, Adrelia Allen, executive director of clinical trial patient diversity at Merck, discusses how the company is embedding diversity into clinical trial execution—from protocol design and ...

In today's ACT Brief, we examine operational RBQM enhanced by AI, how statisticians ensure responsible data use across ...